C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/22/2004	EP1487867A2 Modified plasminogen activator inhibitor type-1 and methods based thereon
12/22/2004	EP1487866A1 Novel polypeptide scaffolds and use thereof
12/22/2004	EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
12/22/2004	EP1487864A2 Therapeutic polypeptides nucleic acids encoding same, and methods of use
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487854A2 Novel isoforms of vascular endothelial ell growth inhibitor
12/22/2004	EP1487853A2 Secretion, transcription and sporulation genes in bacillus clausii
12/22/2004	EP1487852A1 Anti-protozoal vaccine
12/22/2004	EP1487776A1 Acid and ester compounds and methods of using the same
12/22/2004	EP1487542A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
12/22/2004	EP1487490A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
12/22/2004	EP1487488A1 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
12/22/2004	EP1487487A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
12/22/2004	EP1487486A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
12/22/2004	EP1487484A2 Use of mixtures of lipopeptides for vaccine production
12/22/2004	EP1487483A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/22/2004	EP1487479A2 Mutant glycoproteins
12/22/2004	EP1487478A2 Interferon beta-like molecules for treatment of stroke
12/22/2004	EP1487477A2 Methods of using flt3-ligand in immunization protocols
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487280A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
12/22/2004	EP1487268A2 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1226278A4 Methods for identifying and using maintenance genes
12/22/2004	EP1196027A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1177311A4 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
12/22/2004	EP1054959A4 High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm
12/22/2004	EP0966531B1 Tazarotene-induced gene 3 (tig3)
12/22/2004	EP0832253B9 Nucleic acid respiratory syncytial virus vaccines
12/22/2004	EP0815236B1 Haemophilus adhesion proteins
12/22/2004	EP0749441B1 Expression and purification of cloned human alpha-fetoprotein
12/22/2004	EP0658200B1 Glucagon receptors
12/22/2004	CN1556863A Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
12/22/2004	CN1556858A Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
12/22/2004	CN1556857A Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
12/22/2004	CN1556856A Vaccines from infectious agents
12/22/2004	CN1556815A Iron regulating protein-2 (IRP-2) as a diagnostic for neurodegenerative disease
12/22/2004	CN1556814A Knock in transgenic mammal containing a non-functional N-terminus of Kv beta 1.1 subunit
12/22/2004	CN1556209A Anti longicorn Bt gene and its application
12/22/2004	CN1181201C LAG-3 splice variants
12/22/2004	CN1181185C Expression of proteolytic enzymes in koji mold in presence of carbon sources
12/22/2004	CN1181096C Cyclic hexapeptide somatostatin analogues
12/22/2004	CN1181095C Gene relative peptide derivant having calcitonin and preparation process thereof
12/22/2004	CN1181094C Hemopoiesis factor and its application
12/22/2004	CN1181093C Extraction of integral membrane proteins
12/22/2004	CN1181092C Conjugates useful in treatment of prostate cancer
12/22/2004	CN1181091C Factor Xa inhibitors
12/21/2004	US6833493 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
12/21/2004	US6833492 Nitrogen transport metabolism
12/21/2004	US6833448 Annexin derivatives with endogenous chelation sites
12/21/2004	US6833446 Plant polynucleotide sequences encoding transcription factors that are components of the cellular transcription apparatus and the use of such polynucleotide sequences in the modification of gene expression
12/21/2004	US6833441 Compositions and methods for generating chimeric heteromultimers
12/21/2004	US6833440 Membrane protein for use in the diagnosis and treatment of nervous system, psychological, vision and brain disorders
12/21/2004	US6833439 IP-10/MIG receptor designated CXCR3, nucleic acids and methods of use therefor
12/21/2004	US6833438 Involves STEAP (six transmembrane epithelial antigen of the prostate); used in diagnosis, therapy and management of various cancers, including prostate cancer, colon cancer, bladder cancer, ovarian cancer and pancreatic cancer
12/21/2004	US6833437 Complement receptor type 1 (CR1)-like sequences
12/21/2004	US6833435 Compositions isolated from bovine tissues and methods for their use
12/21/2004	US6833356 Binds to antibody specific for Sp36; effective against wide variety of streptococcal and staphylococcal diseases
12/21/2004	US6833355 Use of protein H as cytostatic agent
12/21/2004	US6833354 Agent for the treatment of bone diseases
12/21/2004	US6833349 Therapy for skin disorders; psoriasis
12/21/2004	US6833348 Inhibiting apoptosis mediated by CD3 T-cell receptor or Fas/Fas-L systems; stimulating lymphocyte activity
12/21/2004	US6833256 Interferon tau mutants and methods for making them
12/21/2004	US6833253 Nucleotide sequences coding polypeptides for use in the prevention of microorganismal infections
12/21/2004	US6833247 Comprises polynucleotide sequences for diagnosing, monitoring, prognosticating, preventing or treating tumors; drug screening; molecular markers
12/21/2004	US6833240 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disease
12/21/2004	US6833239 Methods to identify modulators of FKHL7 DNA-binding activity
12/21/2004	US6833237 Methods for treating the effects of stroke, hypoxia and/or ischemia by regulating such genes or proteins
12/21/2004	US6833192 Coating bio-crystal template polymers with alternating layers of charged polyelectrolytes and/or nanparticles
12/21/2004	US6833150 Spray -dried bacteriocin powder with anti-microbial activity
12/21/2004	US6833136 Treatment of Pythium insidiosum infections; animal model for evaluating Pythium insidiosum vaccines
12/21/2004	US6833134 Immunization of dairy cattle with GapC protein against Streptococcus infection
12/21/2004	US6833133 Escape mutants of Newcastle disease virus as marker vaccines
12/21/2004	US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity
12/21/2004	US6832636 Fuel nozzle lever, a fuel nozzle and a method of operating a fuel nozzle
12/21/2004	CA2114788C Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants
12/19/2004	CA2454705A1 Prevention of uveitis
12/16/2004	WO2004109292A2 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs
12/16/2004	WO2004109291A2 Method for diagnosis and therapy of hazelnut-induced systemic reaction
12/16/2004	WO2004108964A1 Differentially regulated hepatocellular carcinoma genes and uses thereof
12/16/2004	WO2004108961A1 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15
12/16/2004	WO2004108955A1 Methods of identifying compounds which modulate granulocite-colony stimulating factor (g-csf) dependent processes by modulation of the levels of a suppressor of cytokine signaling (socs)
12/16/2004	WO2004108946A2 Crystals of herpes simplex virus 1 dna polymerase and/or herpes simplex virus 1 dna polymerase-like proteins and the use thereof
12/16/2004	WO2004108939A2 Bav packaging regions and e1 transcriptional control regions
12/16/2004	WO2004108937A1 Cell surface expression vector of sars virus antigen and microorganisms transformed thereby
12/16/2004	WO2004108936A1 Flavivirus replicon packaging system
12/16/2004	WO2004108932A1 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a seca protein with increased levels of protein secretion, and method for producing proteins
12/16/2004	WO2004108931A1 Cytokinin receptor ahk3 involved in senescence regulation of plant and use thereof
12/16/2004	WO2004108930A1 Genes participating in fgf signal transduction
12/16/2004	WO2004108928A1 Cholesterol biosynthesis pathway modulators and uses thereof
12/16/2004	WO2004108927A1 Laminin 5b
12/16/2004	WO2004108924A1 Cd9/cd81 double-null nonhuman animal
12/16/2004	WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004	WO2004108922A2 Use of aav comprising a capsid protein from aav7 or aav8 for the delivery of genes encoding apoprotein a or e genes to the liver
12/16/2004	WO2004108921A1 Method of nucleic acid infusion
12/16/2004	WO2004108920A1 Method of screening anti-obestic medicine, and obesity model animal
12/16/2004	WO2004108915A1 Fusion protein containing a dimerisation domain and an autotransporter domain
12/16/2004	WO2004108900A2 Plant transcriptional regulators of disease resistance
12/16/2004	WO2004108885A2 Fc chimeric proteins with anti-hiv drugs
12/16/2004	WO2004108883A2 Transducible dna-binding proteins

1 ... 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 ... 2916